{"id":"W2513795393","doi":"10.1016/j.jid.2016.06.070","title":"053 Evaluation of inflammatory bowel disease in patients with plaque psoriasis studied in phase 3 trials of ixekizumab (UNCOVER Trials): Adjudicated data from the induction period","year":2016,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ixekizumab; Medicine; Adverse effect; Incidence (geometry); Placebo; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Psoriasis; Disease; Dermatology; Pathology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003589863,0.0007282569,0.002005941,0.0003134634,0.0004261333,0.001029223,0.0004002744,0.0008095264,0.002760459],"category_scores_gemma":[0.002258567,0.0003547494,0.002326668,0.0004323167,0.0005225813,0.0007432296,0.0003083951,0.001942654,0.0005744337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005170933,"about_ca_system_score_gemma":0.0007337351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003755365,"about_ca_topic_score_gemma":0.001095116,"domain_scores_codex":[0.9978364,0.001522917,0.0001380887,0.0001668515,0.0001534063,0.0001823463],"domain_scores_gemma":[0.9979039,0.000853379,0.0005635601,0.0002333474,0.0001585837,0.0002872545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8607276,0.002531502,0.0379658,0.0007970474,0.00287901,0.000143297,0.0001100638,0.000560058,0.008933347,0.0001976458,0.001671285,0.08348324],"study_design_scores_gemma":[0.394082,0.3759031,0.2032012,0.0003160197,0.005535629,0.0006452744,0.0001955046,0.001480566,0.007977083,0.000739269,0.009842436,0.00008192664],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861491,0.007518165,0.0005195022,0.0003624604,0.0001516873,0.000491359,0.001350636,0.00003928188,0.003417917],"genre_scores_gemma":[0.9953525,0.001179827,0.0005150376,0.0003560502,0.0001403166,0.0002761668,0.001278869,0.00001214021,0.0008889899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003589863,"threshold_uncertainty_score":0.01898527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1123317299465955,"score_gpt":0.3324804203605718,"score_spread":0.2201486904139763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}